TABLE 1.
Characteristics of the 24 patients suspected of having cutaneous leprosya
| Patient code | Sex | Age (yrs) | Location of the patient | Antileprosy treatment before sampling | Clinical form (WHO criteria) |
|---|---|---|---|---|---|
| P1 | M | 64 | Bobo-Dioulasso (BF) | No | PB |
| P2 | M | 26 | Dogoma (BF) | No | MB |
| P3 | F | 57 | Bobo-Dioulasso (BF) | No | PB |
| P4 | M | 60 | Vavoua (CI) | No | MB |
| P5 | M | 46 | Koundougou (BF) | Yes | PB |
| P6 | F | 65 | Bobo-Dioulasso (BF) | No | PB |
| P7 | F | 20 | Karangasso (BF) | No | PB |
| P8 | F | 60 | Deguelin (BF) | No | PB |
| P9 | F | 57 | Bobo-Dioulasso (BF) | No | PB |
| P10 | M | 30 | Dano (BF) | No | PB |
| P11 | M | 21 | Bobo-Dioulasso (BF) | No | PB |
| P12 | F | 29 | Bobo-Dioulasso (BF) | No | PB |
| P13 | M | 45 | Bobo-Dioulasso (BF) | No | PB |
| P14 | M | 64 | Bobo-Dioulasso (BF) | No | PB |
| P15 | M | 24 | Bobo-Dioulasso (BF) | No | PB |
| P16 | M | 21 | Bobo-Dioulasso (BF) | No | PB |
| P17 | M | 77 | Vavoua (CI) | No | PB |
| P18 | M | 15 | Boundiali (CI) | No | PB |
| P19 | F | 29 | Baré (BF) | Yes | PB |
| P20 | F | 41 | Bobo-Dioulasso (BF) | No | PB |
| P21 | M | 20 | Bama (BF) | No | MB |
| P22 | F | 35 | Bobo-Dioulasso (BF) | No | PB |
| P23 | M | 28 | Bobo-Dioulasso (BF) | No | PB |
| P24 | M | 33 | Bobo-Dioulasso (BF) | No | PB |
a
F, female; M, male; BF, Burkina Faso; CI, Côte d’Ivoire; MB, multibacillary; PB, paucibacillary.